Publication | Closed Access

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Type 1Diabetes ManagementInsulin DegludecDiabetesInsulin ManagementBasal-bolus TreatmentDiabetes MellitusInsulin DeliveryMedicineInsulin Signaling